Unibest
← Back to patent-cliff list

CAS 113020-21-6

1-(methoxycarbonyl)cyclopropane-1-carboxylic acid

Codes: DCC-2618-007, ANLO-002

Application context (from source-drug indications)

Gastrointestinal stromal tumourRipretinibAlveolar soft part sarcomaAnlotinib DihydrochlorideHepatocellular carcinomaAnlotinib DihydrochlorideEndometrial cancerAnlotinib DihydrochlorideThyroid cancerAnlotinib DihydrochlorideMedullary thyroid cancerAnlotinib DihydrochlorideSmall cell lung cancerAnlotinib Dihydrochloride

Source drugs (routes using this intermediate)

DrugTierExpiry
RipretinibTier C — Watch / trade2032
Anlotinib DihydrochlorideTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.